Jamp Abacavir / Lamivudine 300 mg (Lamivudine TABLET) 300 MG

JAMP Abacavir / Lamivudine 300 mg tablets are a combination antiretroviral medication used to manage HIV infection. This oral treatment helps control the virus and improve immune function.

Strength

300 MG

Manufacturer / TM Owner

JAMP PHARMA CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JAMP Abacavir / Lamivudine 300 mg tablets are primarily used in the treatment of HIV infection. This combination therapy works by reducing the amount of HIV in the body, which helps to slow the progression of the disease and improve immune system function. It is often prescribed as part of a broader antiretroviral regimen to manage HIV.

Side Effects

Common effects of JAMP Abacavir / Lamivudine 300 mg tablets may include nausea, headache, and fatigue. Some individuals might experience skin rash or changes in body fat distribution. These effects vary and are not experienced by everyone.

Precautions & Warnings

JAMP Abacavir / Lamivudine 300 mg tablets should be handled with care. It is important to inform your healthcare provider about any allergies or pre-existing conditions before starting this medication. Regular monitoring may be required to ensure the medication's safety and effectiveness.

Avoid Interactions

JAMP Abacavir / Lamivudine 300 mg tablets may interact with other medications, including certain antiretrovirals and drugs metabolized by the liver. Alcohol and other substances may also affect how this medication works. Always consult a healthcare provider before combining treatments.

Frequently Asked Questions

JAMP Abacavir / Lamivudine 300 mg tablets are used to manage HIV infection by reducing the amount of virus in the body.

These tablets are taken orally, typically as directed by a healthcare provider. Always follow the prescribed dosage and schedule.

Common side effects may include nausea, headache, fatigue, and skin rash. Not everyone experiences these effects.

Potential interactions with other medications exist, so it's important to consult a healthcare provider before combining treatments.

JAMP Abacavir / Lamivudine 300 mg tablets are manufactured by JAMP Pharma Corporation in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.